>
Switch to:

Horizon Therapeutics Total Inventories

: $237 Mil (As of Sep. 2021)
View and export this data going back to 2011. Start your Free Trial

Horizon Therapeutics's total inventories for the quarter that ended in Sep. 2021 was $237 Mil. Horizon Therapeutics's average total inventories from the quarter that ended in Jun. 2021 to the quarter that ended in Sep. 2021 was $248 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Horizon Therapeutics's Net-Net Working Capital per share for the quarter that ended in Sep. 2021 was $-10.54.

Inventory can be measured by days sales of inventory (DSI). Horizon Therapeutics's days sales of inventory (DSI) for the three months ended in Sep. 2021 was 21.83.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Horizon Therapeutics's Days Inventory for the three months ended in Sep. 2021 was 89.95.

Inventory Turnover measures how fast the company turns over its inventory within a year. Horizon Therapeutics's Inventory Turnover for the quarter that ended in Sep. 2021 was 1.01.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Horizon Therapeutics's Inventory-to-Revenue for the quarter that ended in Sep. 2021 was 0.24.


Horizon Therapeutics Total Inventories Historical Data

The historical data trend for Horizon Therapeutics's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Horizon Therapeutics Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20
Total Inventories
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 184.98 73.07 50.75 53.80 75.28

Horizon Therapeutics Quarterly Data
Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21
Total Inventories Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 77.10 75.28 238.31 258.68 237.43

Horizon Therapeutics Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.


Horizon Therapeutics  (NAS:HZNP) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

Horizon Therapeutics's Net-Net Working Capital Per Share for the quarter that ended in Sep. 2021 is

Net-Net Working Capital Per Share (Q: Sep. 2021 )
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(1068.547+0.75 * 775.371+0.5 * 237.434-4158.474
-0-0)/226.642
=-10.54

2. Inventory can be measured by Days Sales of Inventory (DSI).

Horizon Therapeutics's Days Sales of Inventory for the three months ended in Sep. 2021 is

Days Sales of Inventory (DSI)
=Total Inventories (Q: Sep. 2021 )/Revenue (Q: Sep. 2021 )*Days in Period
=248.055/1036.992*365 / 4
=21.83

3. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Horizon Therapeutics's Days Inventory for the three months ended in Sep. 2021 is calculated as:

Days Inventory=Total Inventories (Q: Sep. 2021 )/Cost of Goods Sold (Q: Sep. 2021 )*Days in Period
=248.055/251.64*365 / 4
=89.95

4. Inventory Turnover measures how fast the company turns over its inventory within a year.

Horizon Therapeutics's Inventory Turnover for the quarter that ended in Sep. 2021 is calculated as

Inventory Turnover=Cost of Goods Sold (Q: Sep. 2021 ) / Total Inventories (Q: Sep. 2021 )
=251.64 / 248.055
=1.01

5. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Horizon Therapeutics's Inventory to Revenue for the quarter that ended in Sep. 2021 is calculated as

Inventory-to-Revenue=Total Inventories (Q: Sep. 2021 ) / Revenue (Q: Sep. 2021 )
=248.055 / 1036.992
=0.24

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.


Horizon Therapeutics Total Inventories Related Terms

Thank you for viewing the detailed overview of Horizon Therapeutics's Total Inventories provided by GuruFocus.com. Please click on the following links to see related term pages.


Horizon Therapeutics Business Description

Horizon Therapeutics logo
Industry
Healthcare » Drug Manufacturers NAICS : 325412 SIC : 2834
Traded in Other Exchanges
Address
1 Burlington Road, Connaught House, 1st Floor, Dublin, IRL, D04 C5Y6
Horizon Therapeutics PLC is a specialty and generic drug manufacturing company. The company is focused on researching, developing and commercializing medicines that address critical needs for people impacted by rare and rheumatic diseases. The company has two reportable segments: orphan and rheumatology segment and the inflammation segment. It markets medicines in the areas of orphan diseases, rheumatology and inflammation division. The majority of revenue is generated in the United States.
Executives
Sherman Jeffrey W officer: EVP and Chief Medical Officer C/O IDM PHARMA, INC. 9 PARKER, SUITE 100 IRVINE CA 92618
Camardo Daniel A. officer: EVP and President, U.S. C/O HORIZON THERAPEUTICS, PLC CONNAUGHT HOUSE, 1ST FL, 1 BURLINGTON RD DUBLIN L2 D04 C5Y6
Konstantinovsky Irina officer: EVP, Chief Human Resources Off C/O HORIZON PHARMA PLC CONNAUGHT HOUSE, 1ST FL, 1 BURLINGTON RD DUBLIN L2 4
Beeler Brian K officer: EVP, General Counsel C/O HORIZON PHARMA PLC 520 LAKE COOK ROAD, SUITE 520 DEERFIELD IL 60015
Hoelscher Paul W. officer: EVP, CFO 520 LAKE COOK ROAD, SUITE 520 C/O HORIZON PHARMA, INC. DEERFIELD IL 60062
Walbert Timothy P director, officer: Chairman, President and CEO 1033 SKOKIE BOULEVARD SUITE 355 NORTHBROOK IL 60062
Grey Michael G director C/O SGX PHARMACEUTICALS, INC. 10505 ROSELLE STREET SAN DIEGO CA 92121
Santini Gino director C/O AMAG PHARMACEUTICALS, INC. 1100 WINTER STREET WALTHAM MA 02451
Karnani Vikram officer: EVP & President, International C/O HORIZON PHARMA PLC, CONNAUGHT HOUSE 1ST FLOOR, 1 BURLINGTON RD DUBLIN L2 4
Witz Pascale director C/O REGULUS THERAPEUTICS INC. 10614 SCIENCE CENTER DRIVE SAN DIEGO CA 92121
Shannon James Samuel director 28903 NORTH AVENUE PAINE VALENCIA CA 91355
Kent Jeff officer: See remarks C/O HORIZON PHARMA PLC CONNAUGHT HOUSE, 1ST FL, 1 BURLINGTON RD DUBLIN L2 4
Moze Barry officer: EVP, Chief Admin. Officer C/O HORIZON PHARMA, INC. 520 EAST COOK ROAD, SUITE 520 DEERFIELD IL 60015
Mchugh Miles W officer: Sr VP & Princ. Acctg Officer C/O ACCRETIVE HEALTH, INC. 401 N. MICHIGAN AVE, SUITE 2700 CHICAGO IL 60611
Curtis Geoffrey M. officer: EVP, Corporate Affairs, CCO C/O HORIZON PHARMA PLC CONNAUGHT HOUSE, 1ST FL, 1 BURLINGTON RD DUBLIN L2 L2 4

Horizon Therapeutics Headlines

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)